TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA FLOW
3.2.1 Data Mining Process
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
3.4.1 Secondary Research data flow:
3.5 PRIMARY RESEARCH:
3.5.1 Primary Research DATA FLOW:
3.5.2 Primary Research: Number of Interviews conducted
3.5.3 Primary Research: Regional Coverage
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1 Revenue Analysis Approach
3.7 DATA FORECASTING
3.7.1 Data forecasting Technique
3.8 DATA END USERLING
3.8.1 microeconomic factor analysis:
3.8.2 Data End Userling:
3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 Growing number of surgical procedures
4.2.2 increasing number of geriatric population
4.3 RESTRAINTS
4.3.1 Complications and risks due to the procedure
4.4 OPPORTUNITY
4.4.1 Increasing incidence of lifestyle disorders and growing technological advancements
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 Manufacturing
5.1.3 Distribution And Sales
5.1.4 Post-Sales Monitoring
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 Threat of New Entrants
5.2.2 Bargaining Power of Suppliers
5.2.3 Threat of Substitutes
5.2.4 Bargaining Power of Buyers
5.2.5 Intensity of Rivalry
5.3 IMPACT OF COVID-19 ON THE GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET
5.3.1 impact on supply chain
5.3.2 IMPACT ON KEY PLAYERS
5.3.3 IMPACT ON DEMAND AND SUPPLY
6 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT
6.1 OVERVIEW
6.2 OPERATING MICROSCOPES
6.3 SUPER MICRO SUTURES
6.4 MICRO FORCEPS
6.5 MICROSURGERY NEEDLE HOLDER
6.6 SURGICAL SCALPEL/ OPHTHALMIC KNIVES
6.7 OTHERS
7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE
7.1 OVERVIEW
7.2 ORTHOPEDIC MICROSURGERY
7.3 OPHTHALMIC MICROSURGERY
7.4 PLASTIC & RECONSTRUCTIVE MICROSURGERY
7.5 ENT MICROSURGERY
7.6 NEUROLOGICAL MICROSURGERY
7.7 GYNECOLOGICAL & UROLOGICAL MICROSURGERY
7.8 OTHERS
8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.3 AMBULATORY SURGICAL CENTERS
8.4 OTHERS
9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
10 GLOBAL MICROSURGERY AND SUPER-MICROSURGERY MARKET, BY REGION
10.1 ASIA-PACIFIC
10.1.1 CHINA
10.1.2 JAPAN
10.1.3 india
10.1.4 Australia
10.1.5 south korea
10.1.6 rest of asia-pacific
10.2 REST OF WORLD
10.2.1 middle east
10.2.2 south america
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 MARKET SHARE ANALYSIS, 2022
11.3 COMPETITOR DASHBOARD
11.4 PUBLIC PLAYERS STOCK SUMMARY
11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
11.6.2 ACQUISITION/INVESTMENT/EXPANSION
11.7 COMPETITOR PRODUCT ANALYSIS
11.7.1 Operating Microscopes
11.7.2 Super Micro Suturess
11.7.3 Super Micro Sutures
11.7.4 Microsurgery Needle Holder
11.7.5 Surgical Scalpel/ Ophthalmic Knives
12 COMPANY PROFILES
12.1 KONTRON AG
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 KEY STRATEGIES
12.2 CARL ZEISS MEDITEC AG
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 PRODUCTS OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 KEY STRATEGIES
12.3 GLOBAL SURGICAL CORPORATION
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 KEY STRATEGIES
12.4 KARL KAPS GMBH & CO. KG
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 KEY STRATEGIES
12.5 MEDTRONIC
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 OLYMPUS CORPORATION
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 KEY STRATEGIES
12.7 SMITH+NEPHEW
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 KEY STRATEGIES
12.8 ZIMMER BIOMET
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 KEY STRATEGIES
12.9 TOPCON CORPORATION
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 KEY STRATEGIES
12.10 STILLE AB
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 KEY STRATEGIES
12.11 B. BRAUN SE
12.11.1 COMPANY OVERVIEW
12.11.2 FINANCIAL OVERVIEW
12.11.3 PRODUCT OFFERed
12.11.4 KEY DEVELOPMENTS
12.11.5 SWOT ANALYSIS
12.11.6 Key Strategy
12.12 STRYKER
12.12.1 COMPANY OVERVIEW
12.12.2 FINANCIAL OVERVIEW
12.12.3 Products OFFERed
12.12.4 KEY DEVELOPMENTS
12.12.5 KEY STRATEGIES
12.13 BVI
12.13.1 COMPANY OVERVIEW
12.13.2 FINANCIAL OVERVIEW
12.13.3 Products OFFERed
12.13.4 KEY DEVELOPMENTS
12.13.5 Key Strategy
12.14 JOHNSON & JOHNSON SERVICES INC
12.14.1 COMPANY OVERVIEW
12.14.2 FINANCIAL OVERVIEW
12.14.3 PRODUCTS OFFERED
12.14.4 KEY DEVELOPMENTS
12.14.5 SWOT ANALYSIS
12.14.6 KEY STRATEGIES
12.15 HAAG-STREIT GROUP
12.15.1 COMPANY OVERVIEW
12.15.2 FINANCIAL OVERVIEW
12.15.3 PRODUCTSOFFERed
12.15.4 KEY DEVELOPMENTS
12.15.5 KEY STRATEGIES
12.16 KLS MARTIN GROUP
12.16.1 COMPANY OVERVIEW
12.16.2 FINANCIAL OVERVIEW
12.16.3 PRODUCT OFFERed
12.16.4 KEY DEVELOPMENTS
12.16.5 KEY STRATEGIES
12.17 MICROSURGERY INSTRUMENTS, INC
12.17.1 COMPANY OVERVIEW
12.17.2 FINANCIAL OVERVIEW
12.17.3 PRODUCTS OFFERed
12.17.4 KEY DEVELOPMENTS
12.17.5 KEY STRATEGIES
12.18 PETER LAZIC GMBH
12.18.1 COMPANY OVERVIEW
12.18.2 FINANCIAL OVERVIEW
12.18.3 PRODUCT OFFERed
12.18.4 KEY DEVELOPMENTS
12.18.5 KEY STRATEGIES
12.19 ALCON INC
12.19.1 COMPANY OVERVIEW
12.19.2 FINANCIAL OVERVIEW
12.19.3 PRODUCT OFFERed
12.19.4 KEY DEVELOPMENTS
12.19.5 KEY STRATEGIES
12.20 SYNOVIS MICRO COMPANIES ALLIANCE, INC
12.20.1 COMPANY OVERVIEW
12.20.2 FINANCIAL OVERVIEW
12.20.3 PRODUCT OFFERed
12.20.4 KEY DEVELOPMENTS
12.20.5 KEY STRATEGIES
13 DATA CITATIONS
LIST OF TABLES
TABLE 1 QFD END USERLING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION)
TABLE 3 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR TOPERATING MICROSCOPES, BY REGION, 2019–2032 (USD MILLION)
TABLE 4 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR SUPER MICRO SUTURES, BY REGION, 2019–2032 (USD MILLION)
TABLE 5 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR MICRO FORCEPS, BY REGION, 2019–2032 (USD MILLION)
TABLE 6 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR MICROSURGERY NEEDLE HOLDER, BY REGION, 2019–2032 (USD MILLION)
TABLE 7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR SURGICAL SCALPEL/ OPHTHALMIC KNIVES, BY REGION, 2019–2032 (USD MILLION)
TABLE 8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION)
TABLE 10 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR ORTHOPEDIC MICROSURGERY, BY REGION, 2019–2032 (USD MILLION)
TABLE 11 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OPHTHALMIC MICROSURGERY, BY REGION, 2019–2032 (USD MILLION)
TABLE 12 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR PLASTIC & RECONSTRUCTIVE MICROSURGERY, BY REGION, 2019–2032 (USD MILLION)
TABLE 13 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR ENT MICROSURGERY, BY REGION, 2019–2032 (USD MILLION)
TABLE 14 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR NEUROLOGICAL MICROSURGERY, BY REGION, 2019–2032 (USD MILLION)
TABLE 15 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR GYNECOLOGICAL & UROLOGICAL MICROSURGERY, BY REGION, 2019–2032 (USD MILLION)
TABLE 16 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 17 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 18 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR HOSPITALS, BY REGION, 2019–2032 (USD MILLION)
TABLE 19 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 20 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 21 GLOBAL: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION, 2019–2032 (USD MILLION)
TABLE 22 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 23 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION)
TABLE 24 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION)
TABLE 25 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 26 US: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION)
TABLE 27 US: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION)
TABLE 28 US: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 29 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION)
TABLE 30 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION)
TABLE 31 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 32 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 33 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION)
TABLE 34 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION)
TABLE 35 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 36 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION)
TABLE 37 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION)
TABLE 38 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 39 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION)
TABLE 40 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION)
TABLE 41 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 42 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION)
TABLE 43 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION)
TABLE 44 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 45 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION)
TABLE 46 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION)
TABLE 47 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 48 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION)
TABLE 49 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION)
TABLE 50 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 51 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019–2032 (USD MILLION)
TABLE 52 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019–2032 (USD MILLION)
TABLE 53 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 54 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2018–2030 (USD MILLION)
TABLE 55 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018–2030 (USD
